30 Lumateperone (ITI-007) for the Treatment of Schizophrenia: Overview of Placebo-Controlled Clinical Trials and an Open-Label Safety Switching Study

CNS Spectrums - United Kingdom
doi 10.1017/s1092852919000245
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Open-Label Placebo Treatment of Women With Premenstrual Syndrome: Study Protocol of a Randomised Controlled Trial

BMJ Open
Medicine
2020English

Hydroxychloroquine in the Treatment of Anti-Histamine Refractory Chronic Spontaneous Urticaria, Randomized Single-Blinded Placebo-Controlled Trial and an Open Label Comparison Study

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Adalimumab for Nail Psoriasis: Efficacy and Safety From the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial

SKIN The Journal of Cutaneous Medicine
2017English

Over-The-Counter Nicotine Patch Therapy for Smoking Cessation: Results From Randomized, Double-Blind, Placebo-Controlled, and Open Label Trials.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1999English

Efficacy and Safety of Two Ayurvedic Dosage Forms for Allergic Rhinitis: Study Protocol for an Open-Label Randomized Controlled Trial

Trials
MedicinePharmacology
2020English

A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)

PLoS ONE
Multidisciplinary
2013English

Efficacy and Safety of Cannabidiol Followed by an Open Label Add-On of Tetrahydrocannabinol for the Treatment of Chronic Pain in Patients With Rheumatoid Arthritis or Ankylosing Spondylitis: Protocol for a Multicentre, Randomised, Placebo-Controlled Study

BMJ Open
Medicine
2019English

Safety of Sildenafil Citrate: Review of 67 Double-Blind Placebo-Controlled Trials and the Postmarketing Safety Database

International Journal of Clinical Practice
Medicine
2009English

Metformin Treatment of Antipsychotic-Induced Dyslipidemia: An Analysis of Two Randomized, Placebo-Controlled Trials

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy